Shefali Samant is a Rheumatology/Immunology physician. OpenAlex indexes 49 publications with 521 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 N Vermont Ave
5th Floor
Los Angeles, CA 900275337
Telephone
800-954-8000Provider last certified this registry record 7 Dec 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pharming Healthcare, Inc.Program year20252 payments
- Pharming Healthcare, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
71.1%Corticosteroid18.8%Breyna71%Fluticasone Propionate29%Part D≥48 patientsHistamine-1 Receptor Antagonist16.8%Azelastine Hcl100%Part D≥73 patients+ 4 more classes in this area
Dermatology
14%Interleukin-4 Receptor alpha Antagonist12.5%Dupixent Syringe69%Dupixent Pen31%Part D<11 patientsCorticosteroid1.5%Triamcinolone Acetonide100%Part D<11 patientsMetabolism & gastrointestinal
7.2%Corticosteroid7.2%Prednisone100%Part D≥40 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Anatomy of Coronary Risk: How Arterial Geometry Shapes Coronary Artery Disease Through Blood Flow Haemodynamics – Latest Methods, Insights and Clinical Implications
Archives of Computational Methods in Engineering
2026 - Evolving paradigms of treatment of allergic and nonallergic rhinitis
Annals of Allergy Asthma & Immunology
2025 - The Perfect Storm: Atypical Hemolytic Uremic Syndrome in a Heart Transplant Recipient
The Journal of Heart and Lung Transplantation
2025 - A Novel PEPD Mutation (Prolidase Deficiency) Presenting as Refractory HLH Treated with Bone Marrow Transplant
Journal of Human Immunity
2025 - Population-Based Incidence of Acute and Chronic Urticaria in Southern California: 2017–2022
The Permanente Journal
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”